Zschiedrich et al. (78) repeatedly measured serum sFRP4 levels in 429 ADPKD patients during 1.5 years follow-up in order to evaluate its prognostic utility. The gene discussed is SFRP4; the disease is autosomal dominant polycystic kidney disease.